Trial Profile
Comparison of modified-release and standard tacrolimus immunosuppression regimens in heart transplant recipients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 18 May 2017 New trial record